Found 10 results
Filters: Author is Uchegbu, Ijeoma F [Clear All Filters]
Nanoparticulate peptide delivery exclusively to the brain produces tolerance free, analgesia.. Journal of Controlled Release. E-pub ahead of print
.
2017. Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments.. Pharmaceutical Research. :1-15.
.
2016. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.. Molecular pharmaceutics. 12(2):420-431.
.
2015. Physical Characterisation and Long‐Term Stability Studies on Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ)—A New Drug Delivery Polymer. Journal of Pharmaceutical Sciences.
.
2014. Strategies To Deliver Peptide Drugs to the Brain. Molecular pharmaceutics. 11(4):1081-1093.
.
2014. Nanofiber-based delivery of therapeutic peptides to the brain. ACS nano. 7(2):1016-1026.
.
2013. Polymer Hydrophobicity Has a Positive Effect on the Oral Absorption of Cyclosporine A from Poly(ethylenimine) Based Nanomedicines. Pharmaceutical Nanotechnology. 1:15-25.
.
2013. A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine 5-enkephalin, to the Brain. Molecular pharmaceutics. 9(6):1665-1680.
.
2012. In silico modelling of drug-polymer interactions for pharmaceutical formulations.. Journal of The Royal Society Interface. 7 Suppl 4:S423-33.
.
2010. Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude.. Biomacromolecules. 7(12):3452-3459.
.
2006.